SEC Says Md. Woman Illegally Traded On FDA Approval Info
By Sydney Price · September 25, 2026, 8:31 PM EDT
The SEC accused a Maryland resident of trading on nonpublic information she received from an insider ahead of the FDA's 2023 denial of a new drug application for a depression treatment...
To view the full article, register now.